CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus Investment Advisers, Inc. | 6,713 | $78,475 | 0.05% |
TWINBEECH CAPITAL LP | 213,460 | $2,495,347 | 0.05% |
CIM INVESTMENT MANAGEMENT INC | 10,888 | $127,281 | 0.05% |
Engineers Gate Manager LP | 102,731 | $1,200,925 | 0.04% |
XML Financial, LLC | 30,000 | $350,700 | 0.04% |
AIGEN INVESTMENT MANAGEMENT, LP | 17,780 | $207,848 | 0.04% |
SHERBROOKE PARK ADVISERS LLC | 10,544 | $123,259 | 0.04% |
Rafferty Asset Management, LLC | 510,435 | $5,966,985 | 0.04% |
LSV ASSET MANAGEMENT | 1,240,769 | $14,505 | 0.03% |
BOOTHBAY FUND MANAGEMENT, LLC | 108,326 | $1,266,331 | 0.03% |
Gotham Asset Management, LLC | 114,006 | $1,332,730 | 0.03% |
Hudson Bay Capital Management LP | 600,000 | $7,014,000 | 0.03% |
Vestcor Inc | 59,615 | $697 | 0.03% |
Renaissance Technologies | 1,289,100 | $15,070 | 0.03% |
XTX Topco Ltd | 13,227 | $154,624 | 0.03% |
BTC Capital Management, Inc. | 18,639 | $217,888 | 0.02% |
Man Group plc | 679,577 | $7,944,255 | 0.02% |
State of Wyoming | 9,616 | $112,411 | 0.02% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 400,159 | $4,677,859 | 0.02% |
E Fund Management Co., Ltd. | 26,220 | $307 | 0.02% |
External links
This page lists CATALYST PHARMACEUTICALS INC's shareholders in Q3 2023. To view CATALYST PHARMACEUTICALS INC's shareholder history, click here.